DYRK Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 5232 | AZ 191 |
| Potent DYRK1B inhibitor | |
| 5632 | AZ Dyrk1B 33 |
| Potent and selective Dyrk1B kinase inhibitor | |
| 7546 | C28 |
| Potent DYRK1α inhibitor; also inhibits LMTK3 | |
| 6638 | GSK 626616 |
| Potent and selective DYRK inhibitor; orally bioavailable. | |
| 5075 | Harmine |
| Potent and selective DYRK1A inhibitor | |
| 4997 | INDY |
| DYRK1A/B inhibitor | |
| 5700 | ML 315 hydrochloride |
| Inhibitor of Clk and DYRK kinases | |
| 7450 | SGC CK2-1 |
| Potent CK2A2 and CK2A1 inhibitor; also inhibits DYRK2 | |
| 7570 | T3 CLK |
| Potent and selective pan-CLK inhibitor; also inhibits DYRK1A/B | |
| 5088 | TC-S 7004 |
| Potent and selective DYRK1A/B inhibitor | |
| 4336 | TG 003 |
| Potent DYRK1A/B inhibitor; also inhibitor of Clk-family kinases |
Alzheimer's Life Science Poster
Written by Dimitra Sokolova and Soyon Hong
Our Alzheimer's disease poster summarizes the genetic, molecular and cellular changes observed in the progression of this neurodegenerative disease.
Request copyDownload PDFParkinson's Life Science Poster
Written by Anthony H.V. Schapira
Our Parkinson's disease (PD) poster summarizes the neurobiology of the disease, and highlights current therapeutic treatments for symptomatic PD.
Request copyDownload PDF